Aluminium hydroxide, magnesium hydroxide, magnesium trisilicate (Gelusil M, Gelusil M Liquid)
Aluminium hydroxide, magnesium hydroxide, magnesium trisilicate
Johnson & Johnson (Pty) Ltd û East London
Every registration of this product has been cancelled.
Registration
- Applicant
- Johnson & Johnson (Pty) Ltd û East London
- Registrations
- 2
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Gelusil m tablets EACH TABLET CONTAINS ALUMINIUM HYDROXIDE 250 mg MAGNESIUM HYDROXIDE 100 mg MAGNESIUM TRISILICATE 500 mg | Tablets | F0135F/11.4.1/135 | Cancelled | Not determined | None |
| Gelusil m liquid EACH 5 ml CONTAINS ALUMINIUM HYDROXIDE 267 mg MAGNESIUM HYDROXIDE 104 mg MAGNESIUM TRISILICATE 515 mg | Not listed | F0136F/11.4.1/136 | Cancelled | Not determined | None |
Regulatory status
This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
Combination product
This product contains more than one active ingredient, so it has no single molecular structure.
SAHPRA documents
SAHPRA has not published a professional information or patient information leaflet for this product.